List of works - Karen Dybkær

A systematic review of molecular responses to cancer therapy in normal human mucosa

scientific article published on 15 August 2017

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

scientific article published on 17 June 2013

Alternative pre-mRNA splicing leads to potential biomarkers in diffuse large B-cell lymphoma - a systematic review

scientific article published on March 2016

Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells

scientific article

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

scientific article published on 23 January 2013

Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy

scientific article

Characterization of memory B cells from thymus and its impact for DLBCL classification

scientific article published on 10 June 2016

Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.

scientific article published on 24 February 2015

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

scientific article published on 29 February 2016

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

scientific article published on 22 March 2012

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis

scientific article

Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-

article

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition

scientific article

Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis

scientific article published in Scientific Reports

Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes

scientific article

Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysis

scientific article

HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells

scientific article

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients

High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma

scientific article published on 5 February 2016

Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma

scientific article

Human Papillomavirus Infection as a Possible Cause of Spontaneous Abortion and Spontaneous Preterm Delivery

scientific article

Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma

scientific article published on 05 June 2015

Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival

scientific article published on 9 April 2017

Long Noncoding RNA Expression during Human B-Cell Development

scientific article published on 22 September 2015

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma

MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review

scientific article published on May 2015

Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa

scientific article

Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission

scientific article published on 11 January 2017

Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma

scientific article published on 16 January 2018

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

scientific article published on 28 August 2012

Performance comparison of Affymetrix SNP6.0 and cytogenetic 2.7M whole-genome microarrays in complex cancer samples

scientific article

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

scientific article

Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium

scientific article published on 26 August 2015

Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor

scientific article published on July 2014

Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study

scientific article published on 7 March 2018

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

scientific article published on 14 June 2016

The myeloma stem cell concept, revisited: from phenomenology to operational terms

scientific article

Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the Literature

scientific article

Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates

scientific article

Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man

scientific article published on 31 January 2014

hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine

scientific article

miR-155 as a Biomarker in B-Cell Malignancies

scientific article

List of works by Karen Dybkær

A systematic review of molecular responses to cancer therapy in normal human mucosa

Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma

Alternative pre-mRNA splicing leads to potential biomarkers in diffuse large B-cell lymphoma - a systematic review

Anti-Apoptotic Effects of Lentiviral Vector Transduction Promote Increased Rituximab Tolerance in Cancerous B-Cells

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy

Characterization of memory B cells from thymus and its impact for DLBCL classification

Circulating tumor necrosis factor-α and YKL-40 level is associated with remission status following salvage therapy in relapsed non-Hodgkin lymphoma.

Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Con

Diffuse large B-cell lymphoma classification system that associates normal B-cell subset phenotypes with prognosis

Erratum: Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-

Exposure time independent summary statistics for assessment of drug dependent cell line growth inhibition

Expression of NOTCH3 exon 16 differentiates Diffuse Large B-cell Lymphoma into molecular subtypes and is associated with prognosis

Gene expression profiling of murine T-cell lymphoblastic lymphoma identifies deregulation of S-phase initiating genes

Global myeloma research clusters, output, and citations: a bibliometric mapping and clustering analysis

HPV16 E6 and E7 Upregulate Interferon-Induced Antiviral Response Genes ISG15 and IFIT1 in Human Trophoblast Cells

High CXCR4 expression impairs rituximab response and the prognosis of R-CHOP-treated diffuse large B-cell lymphoma patients

High miR-34a expression improves response to doxorubicin in diffuse large B-cell lymphoma

Human B-cell cancer cell lines as a preclinical model for studies of drug effect in diffuse large B-cell lymphoma and multiple myeloma

Human Papillomavirus Infection as a Possible Cause of Spontaneous Abortion and Spontaneous Preterm Delivery

Inherited variation in immune response genes in follicular lymphoma and diffuse large B-cell lymphoma

Interactions between SNPs affecting inflammatory response genes are associated with multiple myeloma disease risk and survival

Long Noncoding RNA Expression during Human B-Cell Development

MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma

MicroRNAs as novel biomarkers in diffuse large B-cell lymphoma--a systematic review

Molecular Characteristics of High-Dose Melphalan Associated Oral Mucositis in Patients with Multiple Myeloma: A Gene Expression Study on Human Mucosa

Molecular classification of tissue from a transformed non-Hogkin's lymphoma case with unexpected long-time remission

Oral mucosa tissue gene expression profiling before, during, and after radiation therapy for tonsil squamous cell carcinoma

Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study

Performance comparison of Affymetrix SNP6.0 and cytogenetic 2.7M whole-genome microarrays in complex cancer samples

Predicting response to multidrug regimens in cancer patients using cell line experiments and regularised regression models

Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL Consortium

Reproducible probe-level analysis of the Affymetrix Exon 1.0 ST array with R/Bioconductor

Subtype assignment of CLL based on B-cell subset associated gene signatures from normal bone marrow - A proof of concept study

The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines

The myeloma stem cell concept, revisited: from phenomenology to operational terms

Treatment of Aggressive NK-Cell Leukemia: A Case Report and Review of the Literature

Unaccounted uncertainty from qPCR efficiency estimates entails uncontrolled false positive rates

Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man

hemaClass.org: Online One-By-One Microarray Normalization and Classification of Hematological Cancers for Precision Medicine

miR-155 as a Biomarker in B-Cell Malignancies